A new superbug has emerged from Pakistan and India. Medical professionals are warning that because of the bug's superior resistance to antibiotics the entire world could be looking at a major epidemic that has to potential to make the H1N1 look like less than the common cold.


 

 

 

 

 

NDM-1, also called New Delhi metallo-B-lactamase-1; named appropriately for the Indian capital New Delhi, aNDM-1llows bacteria to be exceptionally resistant to quite nearly every known antibiotic. Even one of the world's most powerful antibiotics, carbapenem, has proven to be no match against this new medical terror. Existing in bacteria such as E. coli, NDM-1 is spreading rapidly all throughout India, Pakistan and Bangladesh. Timothy Walsh, a leading researched from England's CardiffUniversity spoke to Reuters on the matter. He is quoted as saying, "At a global level, this is a real concern because of the medical tourism and international travel in general, resistance to these types of bacteria has the potential to spread around the world very, very quickly. And there is nothing in the pipeline to tackle it."


 

 

 

 

 

In a report to the journal of Lancet Infectious Diseases this Wednesday, British scientists say that NDM-1 has been identified in roughly 50 individuals from the United Kingdom who have recently traveled to either Pakistan or India for cosmetic procedures. Over the past few years India has seen a rise in travelers seeking lower cost cosmetic surgery. Most; but not all, of those who travel to India for such plastic surgery procedures are from the UK, Canada and the United States.


 

 

 

 

 

Antibiotics were first introduced to the world in the 1940s in the form of penicillin. Since their debut, bacteria began to develop resistance against its effects. In turn, scientists are constantly developing new generations of antibiotics. As the antibiotics become stronger, so do the bacteria that they are attempting to combat.